Pinealon
Purported geroprotective agent
From Wikipedia, the free encyclopedia
Pinealon, also known as EDR peptide, is a synthetic tripeptide of sequence (Glu-Asp-Arg) and purported geroprotector documented in the Russian scientific literature.[1][2][3][4][5][6] Pinealon is one of several tripeptide "bioregulators" developed in Russia.[7][8][9]
| Clinical data | |
|---|---|
| Other names | Glu-Asp-Arg |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ChEBI | |
| Chemical and physical data | |
| Formula | C15H26N6O8 |
| Molar mass | 418.407 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Research
Pinealon has been shown to protect rat offspring from prenatal hyperhomocysteinemia and correspondingly improve post natal cognitive function.[10]
Pinealon likewise maintains learning retention rats with experimentally-induced diabetes.[11]
Chemistry
Pinealon is a tripeptide composed of L-glutamic acid, L-aspartic acid, and L-arginine and is notated as Glu-Asp-Arg or EDR.[12]